Pediatrix to Change its Name to MEDNAX, Inc.

  
    
  
  
    
      Pediatrix Medical Group, Inc. (NYSE:PDX) announced that the Company will 
      change its name to MEDNAX, Inc., to reflect the Company’s 
      development as a national medical group that provides services beyond 
      its historical pediatric and maternal-fetal physician subspecialties.
    
    
      Pediatrix’s stock symbol on the New York Stock 
      Exchange will become “MD” 
      at the same time that the name change becomes effective, which is 
      expected to occur at the beginning of 2009.
    
    
      “This name change is in recognition of what we 
      have become over the past several years, a physician services 
      organization that has expanded beyond our roots as a single specialty 
      organization,” said Roger J. Medel, M.D., the 
      Company’s Chief Executive Officer. “Today 
      our scope includes a clinical continuum around maternal-fetal, newborn 
      and pediatric subspecialty care, as well as the development of our 
      national anesthesia group. The MEDNAX name reflects our commitment to 
      medical care, as well as our national presence. Our dedication to 
      patient care, which has been synonymous with Pediatrix, will be extended 
      to MEDNAX.”
    
    
      MEDNAX, Inc., will be organized as a new holding company with Pediatrix 
      Medical Group and American Anesthesiology as its principal subsidiaries. 
      As part of the tax-free reorganization, each share of Pediatrix common 
      stock will become a share of MEDNAX, Inc.
    
    
      The Pediatrix subsidiary’s operations will 
      include the Company’s historic physician 
      services in the neonatal, maternal-fetal, pediatric cardiology, and 
      pediatric intensive care subspecialties, as well as the Company’s 
      newborn hearing screen program. American Anesthesiology was formed in 
      2007 and currently includes anesthesia physician services provided to 
      patients in northern Virginia and Atlanta, Georgia.
    
    
      Physicians and advanced practitioners will continue to practice under 
      the Pediatrix and American Anesthesiology subsidiaries.
    
    
      About Pediatrix
    
    
      Pediatrix Medical Group, Inc. is the nation’s 
      leading provider of neonatal, maternal-fetal and pediatric physician 
      subspecialty services and recently expanded to include anesthesiology 
      services. Pediatrix physicians and advanced practitioners are reshaping 
      the delivery of care within the maternal-fetal, neonatal intensive care 
      and pediatric cardiology subspecialties, using evidence-based tools, 
      continuous quality initiatives and clinical research to enhance patient 
      outcomes and provide high-quality, cost-effective care. Founded in 1979, 
      its neonatal physicians provide services at more than 250 neonatal 
      intensive care units, and in many markets they collaborate with 
      affiliated maternal-fetal medicine, pediatric cardiology physician 
      subspecialists and pediatric intensivists to provide a clinical care 
      continuum. Combined, Pediatrix and its affiliated professional 
      corporations employ more than 1,100 physicians in 32 states and Puerto 
      Rico. Pediatrix is also the nation’s largest 
      provider of newborn hearing screens. Additional information is available 
      at www.pediatrix.com.
    
    
      Certain statements and information in this press release may be 
      deemed to be “forward-looking statements” 
      within the meaning of the Federal Private Securities Litigation Reform 
      Act of 1995. Forward-looking statements may include, but are not 
      limited to, statements relating to our objectives, plans and strategies, 
      and all statements (other than statements of historical facts) that 
      address activities, events or developments that we intend, expect, 
      project, believe or anticipate will or may occur in the future are 
      forward-looking statements. These statements are often characterized by 
      terminology such as “believe”, 
      “hope”, “may”, 
      “anticipate”, “should”, 
      “intend”, “plan”, 
      “will”, “expect”, 
      “estimate”, “project”, 
      “positioned”, “strategy” 
      and similar expressions, and are based on assumptions and assessments 
      made by Pediatrix’s management in light of 
      their experience and their perception of historical trends, current 
      conditions, expected future developments and other factors they believe 
      to be appropriate. Any forward-looking statements in this press release 
      are made as of the date hereof, and Pediatrix undertakes no duty to 
      update or revise any such statements, whether as a result of new 
      information, future events or otherwise. Forward-looking statements are 
      not guarantees of future performance and are subject to risks and 
      uncertainties. Important factors that could cause actual results, 
      developments, and business decisions to differ materially from 
      forward-looking statements are described in Pediatrix’s 
      most recent Annual Report on Form 10-K, including the section entitled “Risk 
      Factors”.